An elevated leptin/adiponectin ratio (L/A ratio) is associated with an increased risk of endometrial cancer in post-menopausal women and the L/A ratio seems to be a better predictor of estimated risk than either leptin or adiponectin alone [43]. The gene discussed is LEP; the disease is endometrial cancer.